Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/12/2021	Renaissance Technologies LLC	40,300	$1.15M	0.0%	N/A	2.034%
11/12/2021	EAM Investors LLC	42,835	$1.21M	0.2%	N/A	2.162%
11/10/2021	O Shaughnessy Asset Management LLC	2,610	$74K	0.0%	N/A	0.132%
11/8/2021	Texas Yale Capital Corp.	9,400	$0.27M	0.0%	N/A	0.475%
8/10/2021	Rockefeller Capital Management L.P.	9,800	$0.19M	0.0%	N/A	0.495%
7/31/2021	Emerald Mutual Fund Advisers Trust	93,600	$1.81M	0.1%	N/A	4.727%

Data available starting January 2016

IKONICS Corp. engages in the development, manufacture, and trade of photochemical imaging products. It operates through the following business segments: Chromaline, IKONICS Imaging, Digital Texturing (DTX) and Advanced Material Solutions (AMS). The Chromaline Segment sells screen printing film, emulsions, and inkjet receptive film primarily to distributors and some end users. The IKONICS Imaging segment develops and sells photo resistant film, art supplies, glass, metal medium, and abrasive etching equipment. The DTX segment includes patented inkjet technology used for mold texturing and prototyping. The AMS segment supplies sound deadening technology to the aerospace industry. The company was founded in 1952 and is headquartered in Duluth, MN.

Today's Range

Now: N/A

50 Day Range

MA: $33.02

$26.61

$42.31

52 Week Range

Now: N/A

Volume

1,394 shs

Average Volume

136,576 shs

Market Capitalization

$67.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

Get the name of the stock here >>>